<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dopamine agents for hepatic encephalopathy - Junker, AE - 2014 | Cochrane Library</title> <meta content="Dopamine agents for hepatic encephalopathy - Junker, AE - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003047.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dopamine agents for hepatic encephalopathy - Junker, AE - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003047.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003047.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Dopamine agents for hepatic encephalopathy" name="citation_title"/> <meta content="Anders Ellekær Junker" name="citation_author"/> <meta content="Gentofte Hospital" name="citation_author_institution"/> <meta content="andjunker@dadlnet.dk" name="citation_author_email"/> <meta content="Bodil Als‐Nielsen" name="citation_author"/> <meta content="The Child and Youth Clinic" name="citation_author_institution"/> <meta content="Christian Gluud" name="citation_author"/> <meta content="Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital" name="citation_author_institution"/> <meta content="Lise Lotte Gluud" name="citation_author"/> <meta content="Copenhagen University Hospital Hvidovre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD003047.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/02/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003047.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003047.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003047.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bromocriptine [*therapeutic use]; Dopamine Agonists [*therapeutic use]; Hepatic Encephalopathy [*drug therapy]; Levodopa [*therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003047.pub3&amp;doi=10.1002/14651858.CD003047.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="XHP2gG4h";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003047\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003047\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003047.pub3",title:"Dopamine agents for hepatic encephalopathy",firstPublishedDate:"Feb 10, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hepato‐Biliary Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XHP2gG4h&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003047.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003047.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003047.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003047.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003047.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003047.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003047.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003047.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003047.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003047.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1360 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003047.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/appendices#CD003047-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/table_n/CD003047StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/table_n/CD003047StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dopamine agents for hepatic encephalopathy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#CD003047-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Anders Ellekær Junker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#CD003047-cr-0003">Bodil Als‐Nielsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#CD003047-cr-0004">Christian Gluud</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information#CD003047-cr-0005">Lise Lotte Gluud</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information/en#CD003047-sec-0083">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 February 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003047.pub3">https://doi.org/10.1002/14651858.CD003047.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003047-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003047-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003047-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003047-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003047-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003047-abs-0001" lang="en"> <section id="CD003047-sec-0001"> <h3 class="title" id="CD003047-sec-0001">Background</h3> <p>Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy. </p> </section> <section id="CD003047-sec-0002"> <h3 class="title" id="CD003047-sec-0002">Objectives</h3> <p>To evaluate the beneficial and harmful effects of dopamine agents versus placebo or no intervention for patients with hepatic encephalopathy. </p> </section> <section id="CD003047-sec-0003"> <h3 class="title" id="CD003047-sec-0003">Search methods</h3> <p>Trials were identified through the Cochrane Hepato‐Biliary Group Controlled Trials Register (January 2014), the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 12 of 12, 2013), MEDLINE (1946 to January 2014), EMBASE (1974 to January 2014), and Science Citation Index‐Expanded (1900 to January 2014). Manual searches in reference lists, conference proceedings, and online trial registers were also performed. </p> </section> <section id="CD003047-sec-0004"> <h3 class="title" id="CD003047-sec-0004">Selection criteria</h3> <p>Randomised trials were included, irrespective of publication status or language. The primary analyses included data from randomised trials using a parallel‐group design or the first period of cross‐over trials. Paired data from cross‐over trials were included in sensitivity analyses. </p> </section> <section id="CD003047-sec-0005"> <h3 class="title" id="CD003047-sec-0005">Data collection and analysis</h3> <p>Three review authors extracted data independently. Random‐effects meta‐analyses were performed as the result of an expected clinical heterogeneity. Fixed‐effect meta‐analyses, meta‐regression analyses, subgroup analyses, and sensitivity analyses were performed to evaluate sources of heterogeneity and bias (systematic errors). Trial sequential analysis was used to control the risk of play of chance (random errors). </p> </section> <section id="CD003047-sec-0006"> <h3 class="title" id="CD003047-sec-0006">Main results</h3> <p>Five trials that randomly assigned 144 participants with overt hepatic encephalopathy that were published during 1979 to 1982 were included. Three trials assessed levodopa, and two trials assessed bromocriptine. The mean daily dose was 4 grams for levodopa and 15 grams for bromocriptine. The median duration of treatment was 14 days (range seven to 56 days). None of the trials followed participants after the end of treatment. Only one trial reported adequate bias control; the remaining four trials were considered to have high risk of bias. Random‐effects model meta‐analyses showed that dopamine agents had no beneficial or detrimental effect on hepatic encephalopathy in the primary analyses (15/80 (19%) versus 14/80 (18%); odds ratio (OR) 2.99, 95% confidence interval (CI) 0.09 to 100.55; two trials) or when paired data from cross‐over trials were included (OR 1.04, 95% CI 0.75 to 1.43). Clear evidence of intertrial heterogeneity was identified both in the primary analysis (I<sup>2</sup> = 65%) and when paired data from cross‐over trials were included (I<sup>2</sup> = 40%). </p> <p>Dopamine agents had no beneficial or harmful effect on mortality (42/144 (29%) versus 38/144 (26%); OR 1.11, 95% CI 0.35 to 3.54; five trials). Trial sequential analyses demonstrated that we lacked information to refute or recommend the interventions for all outcomes. Dopamine agonists did not seem to increase the risk of adverse events. </p> </section> <section id="CD003047-sec-0007"> <h3 class="title" id="CD003047-sec-0007">Authors' conclusions</h3> <p>This review found no evidence to recommend or refute the use of dopamine agents for hepatic encephalopathy. More randomised placebo‐controlled clinical trials without risks of systematic errors and risks of random errors seem necessary to permit firm decisions on dopamine agents for patients with hepatic encephalopathy. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003047-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003047-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003047-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003047-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003047-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003047-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003047-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003047-abs-0004" lang="en"> <h3>Dopamine agents for hepatic encephalopathy</h3> <p>Hepatic encephalopathy is a serious complication of severe liver disease. The disease is often fluctuating with a wide spectrum of symptoms ranging from minor, not readily discernible signs to deep coma. Symptoms often develop in connection to stress related to infection, dehydration, obstipation, or gastrointestinal bleeding. The exact underlying mechanisms behind the disease development are not known. Experimental studies suggest that the mental changes seen in hepatic encephalopathy reflect changes in neurotransmitters in the brain. </p> <p>Dopamine plays a major role in neurotransmission. Several nervous system diseases including Parkinson's disease are caused by a dysfunction in the dopamine system. Some patients with hepatic encephalopathy have symptoms that are similar to those seen in patients with Parkinson's disease (slow cerebration; stiffness of movements; tremor). For patients with Parkinson's disease, the drugs known as dopamine agents (drugs that mimic the effect of the neurotransmitter dopamine) clearly alleviate symptoms. These drugs have also been assessed for patients with hepatic encephalopathy. </p> <p>We performed the present systematic review to determine the beneficial and harmful effects of dopamine agents for patients with hepatic encephalopathy. Our analyses included five small trials published in 1982 or earlier. All trials but one had high risks of bias (i.e., risks of systematic errors or risks of overestimation of beneficial effects or risks of underestimation of harmful effects). Only 144 patients were included in the five trials, and accordingly risks of random errors (i.e., play of chance) are present. Our analyses showed no significant differences regarding symptoms of hepatic encephalopathy or mortality in patients treated with dopamine agents compared with patients who received an inactive placebo or no intervention. The number of patients with adverse events seemed comparable in the two intervention groups. Based on the available evidence, we conclude that no evidence can be found to recommend or refute the use of dopamine agents for hepatic encephalopathy. More randomised placebo‐controlled clinical trials without risks of systematic errors and risks of random errors seem necessary to obtain firm evidence on dopamine agents for patients with hepatic encephalopathy. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003047-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003047-sec-0074"></div> <h3 class="title" id="CD003047-sec-0075">Implications for practice</h3> <section id="CD003047-sec-0075"> <p>This review does not provide evidence to recommend or refute the use of dopamine agents for patients with hepatic encephalopathy. </p> </section> <h3 class="title" id="CD003047-sec-0076">Implications for research</h3> <section id="CD003047-sec-0076"> <p>However, we cannot exclude the possibility that dopamine agents may have beneficial effects that were overlooked because of the limited statistical power of the included trials. On the other hand, other interventions for hepatic encephalopathy (such as non‐absorbable disaccharides, branched chain amino acids, and antibiotics) appear potentially more promising than dopamine agents (<a href="./references#CD003047-bbs2-0016" title="Als‐NielsenB , GluudLL , GluudC . Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003044.pub2] ">Als‐Nielsen 2004a</a>; <a href="./references#CD003047-bbs2-0019" title="BassNM , MullenKD , SanyalA , PoordadF , NeffG , LeevyCB , et al. Rifaximin treatment in hepatic encephalopathy. New England Journal of Medicine2010;362(12):1071‐81. [PUBMED: 20335583] ">Bass 2010</a>; <a href="./references#CD003047-bbs2-0039" title="LesI , DovalE , Garcia‐MartinezR , PlanasM , CardenasG , GomezP , et al. Effects of branched‐chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. American Journal of Gastroenterology2011;106(6):1081‐8. [PUBMED: 21326220] ">Les 2011</a>). The value of additional trials on dopamine agents is questionable. Should anyone wish to conduct further trials, we recommend that the dopamine agent used should be tested against placebo in parallel‐group superiority trials conducted according to the SPIRIT guidelines (<a href="./references#CD003047-bbs2-0053" title="ChanAW , TetzlaffJM , AltmanDG , LaupacisA , GøtzschePC , Krleža‐JerićK , et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Annals of Internal Medicine2013;158:200‐7. ">SPIRIT 2013</a>; <a href="./references#CD003047-bbs2-0054" title="ChanA‐W , TetzlaffJM , GøtzschePC , AltmanDG , MannH , BerlinJ , et al. SPIRIT 2013 Explanation and Elaboration: Guidance for protocols of clinical trials. BMJ (Clinical Research Ed.)2013;346:e7586. ">SPIRIT 2013a</a>) and reported according to the CONSORT guidelines (<a href="http://www.consort-statement.org" target="_blank">www.consort‐statement.org</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003047-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003047-sec-0022"></div> <div class="table" id="CD003047-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dopamine agonists for hepatic encephalopathy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Dopamine agonists versus placebo or no intervention for hepatic encephalopathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with hepatic encephalopathy.<br/> <b>Settings:</b> hospitalised patients.<br/> <b>Intervention:</b> dopamine agonists versus placebo or no intervention. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control (placebo or no intervention)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Dopamine agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> <br/> Follow‐up: mean one month </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.11</b> <br/> (0.35 to 3.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>144<br/> (five studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>535 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> <br/> (287 to 803) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>395 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>420 per 1000</b> <br/> (186 to 698) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Hepatic encephalopathy</b> <br/> Follow‐up: mean one month </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.99</b> <br/> (0.09 to 100.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>80<br/> (two studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>350 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>617 per 1000</b> <br/> (46 to 982) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>184 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>403 per 1000</b> <br/> (20 to 958) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The randomisation methods were classed as adequate in two trials, and three trials were double‐blind.<br/> <sup>2</sup>The sample size was small, and the statistical power of included trials was weak.<br/> <sup>3</sup>Because of the small number of trials, tests for publication bias were of limited value. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003047-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003047-sec-0023"></div> <section id="CD003047-sec-0024"> <h3 class="title" id="CD003047-sec-0024">Description of the condition</h3> <p>Hepatic encephalopathy is a complex neuropsychiatric syndrome seen in severe liver failure (<a href="./references#CD003047-bbs2-0029" title="GitlinN . Hepatic encephalopathy. In: ZakimD , BoyerT editor(s). Hepatology. A Textbook of Liver Disease. 3rd Edition. Vol. 1, Philadelphia: WB Saunders Company, 1996:605‐17. ">Gitlin 1996</a>; <a href="./references#CD003047-bbs2-0028" title="FerenciP , LockwoodA , MullenK , TarterR , WeissenbornK , BleiAT . Hepatic encephalopathy ‐ definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology2002;35:716‐21. [MEDLINE: PM 11870389] ">Ferenci 2002</a>). Symptoms range from minor neuropsychiatric changes to deep coma (<a href="./references#CD003047-bbs2-0024" title="ConnH , LieberthalM . The Hepatic Coma Syndromes and Lactulose. Baltimore: Williams &amp; Wilkins, 1979. ">Conn 1979</a>). Hepatic encephalopathy may be clinically overt or may consist of mild neurocognitive impairments, which have been identified in a substantial percentage of patients with liver disease (<a href="./references#CD003047-bbs2-0046" title="RandolphC , HilsabeckR , KatoA , KharbandaP , LiYY , MapelliD , et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver International2009;29(5):629‐35. [PUBMED: 19302444] ">Randolph 2009</a>). The course of the disease may be episodic, with recurrent symptoms, or chronic, with more stable symptoms (<a href="./references#CD003047-bbs2-0017" title="BajajJS , CordobaJ , MullenKD , AmodioP , ShawcrossDL , ButterworthRF , et al. Review article: the design of clinical trials in hepatic encephalopathy ‐ an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Alimentary Pharmacology &amp; Therapeutics2011;33(7):739‐47. [PUBMED: 21306407] ">Bajaj 2011</a>). The exact underlying pathophysiology is not known. Experimental studies suggest that symptoms develop as the result of accumulation of toxic agents that have not been metabolised by the liver (<a href="./references#CD003047-bbs2-0029" title="GitlinN . Hepatic encephalopathy. In: ZakimD , BoyerT editor(s). Hepatology. A Textbook of Liver Disease. 3rd Edition. Vol. 1, Philadelphia: WB Saunders Company, 1996:605‐17. ">Gitlin 1996</a>). Other potential mechanisms include the generation of false neurotransmitters and an abnormal interaction between astrocytes and other cellular elements with cerebral oedema and alterations in glioneural communication (<a href="./references#CD003047-bbs2-0032" title="HaussingerD , KircheisG , FischerR , SchliessF , vom DahlS . Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low‐grade cerebral edema?. Journal of Hepatology2000;32:1035‐8. [MEDLINE: PMID: 10898326] ">Haussinger 2000</a>; <a href="./references#CD003047-bbs2-0025" title="CordobaJ , AlonsoJ , RoviraA , JacasC , SanpedroF , CastellsL , et al. The development of low‐grade cerebral edema in cirrhosis is supported by the evolution of (1)H‐magnetic resonance abnormalities after liver transplantation. Journal of Hepatology2001;35:598‐604. [MEDLINE: PM 11690705] ">Cordoba 2001</a>). </p> </section> <section id="CD003047-sec-0025"> <h3 class="title" id="CD003047-sec-0025">Description of the intervention</h3> <p>Many patients with hepatic encephalopathy present with extrapyramidal symptoms and have changes in the basal ganglia, as detected by magnetic resonance imaging and proton spectroscopy (<a href="./references#CD003047-bbs2-0052" title="SpahrL , VingerhoetsF , LazeyrasF , DelavelleJ , DuPasquierR , GiostraE , et al. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology2000;119:774‐81. [MEDLINE: 10982772] ">Spahr 2000</a>). These symptoms are comparable with those seen in Parkinson's disease and suggest an impairment of dopamine neurotransmission (<a href="./references#CD003047-bbs2-0021" title="BleiA . Hepatic encephalopathy. In: BircherJ , BenhamouJ‐P , McIntyreN , RizzettoM , RodésJ editor(s). Clinical Hepatology. 2nd Edition. Vol. 1, Oxford: Oxford University Press, 1999:765‐83. ">Blei 1999</a>; <a href="./references#CD003047-bbs2-0037" title="JoverR , CompanyL , GutierrezA , ZapaterP , Perez‐SerraJ , GironaE , et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. American Journal of Gastroenterology2003;98:1599‐604. [MEDLINE: PMID: 12873585] ">Jover 2003</a>). Patients with Parkinson's disease are less likely to experience dyskinesia and dystonia when treated with levodopa (<a href="./references#CD003047-bbs2-0056" title="StoweR , IvesN , ClarkeCE , vanHilten , FerreiraJ , HawkerRJ , et al. Dopamine agonist therapy in early Parkinson's disease. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD006564.pub2; PUBMED: 18425954] ">Stowe 2008</a>). Uncontrolled trials suggest that levodopa or bromocriptine could be beneficial in the treatment of patients with hepatic encephalopathy (<a href="./references#CD003047-bbs2-0044" title="ParkesJD , SharpstoneP , WilliamsR . Levodopa in hepatic coma. Lancet1970;2(7687):1341‐3. [MEDLINE: 4098911] ">Parkes 1970</a>; <a href="./references#CD003047-bbs2-0008" title="JorgeAD , SanchezD . Effect of L‐dopa on hepatic coma [Die Wirkung des L‐Dopa im Coma hepaticum]. Schweizerische Rundschau für Medizin Praxis1973;62(27):868‐72. [MEDLINE: 4578027] ">Jorge 1973</a>). The effects of dopamine agents have also been assessed in randomised clinical trials (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>), and previous guidelines suggested that the intervention may be considered in patients with chronic hepatic encephalopathy (<a href="./references#CD003047-bbs2-0021" title="BleiA . Hepatic encephalopathy. In: BircherJ , BenhamouJ‐P , McIntyreN , RizzettoM , RodésJ editor(s). Clinical Hepatology. 2nd Edition. Vol. 1, Oxford: Oxford University Press, 1999:765‐83. ">Blei 1999</a>; <a href="./references#CD003047-bbs2-0040" title="Lizardi‐CerveraJ , AlmedaP , GuevaraL , UribeM . Hepatic encephalopathy: a review. Annals of Hepatology2003;2:122‐30. [MEDLINE: PMID: 15115963] ">Lizardi‐Cervera 2003</a>). </p> </section> <section id="CD003047-sec-0026"> <h3 class="title" id="CD003047-sec-0026">Why it is important to do this review</h3> <p>We have previously published a systematic review on dopamine agents for hepatic encephalopathy (<a href="./references#CD003047-bbs2-0016" title="Als‐NielsenB , GluudLL , GluudC . Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003044.pub2] ">Als‐Nielsen 2004a</a>). The results of this review were inconclusive. We have been unable to identify any further meta‐analyses or systematic reviews on the topic. To determine the strengths and weaknesses of the current evidence, we have updated our previous review (<a href="./references#CD003047-bbs2-0016" title="Als‐NielsenB , GluudLL , GluudC . Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003044.pub2] ">Als‐Nielsen 2004a</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003047-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003047-sec-0027"></div> <p>To evaluate the beneficial and harmful effects of dopamine agents versus placebo or no intervention for patients with hepatic encephalopathy. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003047-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003047-sec-0028"></div> <section id="CD003047-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003047-sec-0030"> <h4 class="title">Types of studies</h4> <p>This review included all randomised trials, regardless of publication status, language, or blinding. Unpublished trials were included if the methodology and the data were available in written form. We planned to include observational studies reporting harms, but we identified no observational studies reporting relevant data. </p> </section> <section id="CD003047-sec-0031"> <h4 class="title">Types of participants</h4> <p>Patients with hepatic encephalopathy were included, irrespective of the aetiology of the underlying liver disease. The diagnostic criteria could include psychometric tests, clinical scoring systems (such as the West‐Haven criteria), electroencephalography (<a href="./references#CD003047-bbs2-0031" title="GueritJM , AmantiniA , FischerC , KaplanPW , MecarelliO , SchnitzlerA , et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver International2009;29(6):789‐96. [PUBMED: 19638107] ">Guerit 2009</a>), or biochemical findings (including ammonia levels). Based on the diagnostic criteria used in the included trials, participants were classified as having overt or minimal hepatic encephalopathy, and the latter was classified further as recurrent or chronic. </p> </section> <section id="CD003047-sec-0032"> <h4 class="title">Types of interventions</h4> <p>The intervention comparisons assessed were dopamine agents (e.g., levodopa, bromocriptine) versus placebo or no intervention. Studies were included irrespective of the dose or duration of therapy. </p> </section> <section id="CD003047-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD003047-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD003047-list-0001"> <li> <p>Mortality (all‐cause).</p> </li> <li> <p>All cause non‐fatal serious adverse events.</p> </li> <li> <p>Morbidity. This outcome measure was assessed on the basis of the number of participants who showed no improvement in manifestations of hepatic encephalopathy as defined by the authors of included trials. </p> </li> </ul> </p> </section> <section id="CD003047-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003047-list-0002"> <li> <p>All‐cause non‐serious adverse events (number and type) (<a href="./references#CD003047-bbs2-0036" title="International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR and ICH Guidelines. Vol. 1, PA 19063‐2043, USA: Barnett International/PAREXEL, 1997. ">ICH‐GCP 1997</a>). </p> </li> <li> <p>Qualitiy of life.</p> </li> </ul> </p> </section> </section> </section> <section id="CD003047-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003047-sec-0037"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Hepato‐Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and Science Citation Index‐Expanded (<a href="./references#CD003047-bbs2-0048" title="RoyleP , MilneR . Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care2003;19(4):591‐603. ">Royle 2003</a>). Search strategies with time spans of the searches are given in <a href="./appendices#CD003047-sec-0080">Appendix 1</a>. </p> </section> <section id="CD003047-sec-0038"> <h4 class="title">Searching other resources</h4> <p>Reference lists in relevant articles and conference proceedings were scanned for additional trials not identified in the electronic searches. We wrote to authors of identified trials and pharmaceutical companies to enquire about additional trials. Ongoing and completed trials were also identified through searches in the World Health Organization Trial Search Portal (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>/). </p> </section> </section> <section id="CD003047-sec-0039"> <h3 class="title" id="CD003047-sec-0039">Data collection and analysis</h3> <section id="CD003047-sec-0040"> <h4 class="title">Selection of studies</h4> <p>All review authors participated in the selection of trials. AEJ listed the potentially eligible trials. Subsequently, trials that fulfilled all inclusion criteria were identified. Excluded trials were listed along with the reasons for exclusion. </p> </section> <section id="CD003047-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (AEJ, BA‐N, and LLG) extracted data independently. All disagreements were resolved through discussion before analyses. </p> <p>We extracted data on the design of the trial (country of origin, parallel or cross‐over design, and bias control), participant characteristics (aetiology of underlying liver diseases and type of hepatic encephalopathy, mean age, proportion of men), and the intervention regimen assessed (type, dose, and duration of therapy). </p> </section> <section id="CD003047-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias in the trials independently in accordance with the instructions provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003047-bbs2-0034" title="HigginsJP , WhiteheadA , SimmondsM . Sequential methods for random‐effects meta‐analysis. Statistics in Medicine2011;30(9):903‐21. [PUBMED: 21472757] ">Higgins 2011</a>) and the Cochrane Hepato‐Biliary Group Module (<a href="./references#CD003047-bbs2-0030" title="GluudC , NikolovaD , KlingenbergSL , AlexakisN , Als‐NielsenB , ColliA , et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). Art. No.: LIVER2013, issue 12. ">Gluud 2013</a>). Because of the risk of overestimation of intervention effects in randomised trials with high risk of bias (<a href="./references#CD003047-bbs2-0051" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>; <a href="./references#CD003047-bbs2-0043" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet1998;352(9128):609‐13. ">Moher 1998</a>; <a href="./references#CD003047-bbs2-0038" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine2001;135(11):982‐9. ">Kjaergard 2001</a>; <a href="./references#CD003047-bbs2-0063" title="WoodL , EggerM , GluudLL , SchulzKF , JuniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.)2008;336(7644):601‐5. [PUBMED: 18316340] ">Wood 2008</a>; <a href="./references#CD003047-bbs2-0041" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>; <a href="./references#CD003047-bbs2-0049" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429‐38. ">Savovic 2012</a>, <a href="./references#CD003047-bbs2-0050" title="SavovicJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1‐82. ">Savovic 2012a</a>), we assessed the influence of risk of bias on trial results using the following domains. </p> <p><b>Allocation sequence generation</b> </p> <p> <ul id="CD003047-list-0003"> <li> <p>Low risk of bias: Sequence generation was achieved by using computer random number generation or a random number table. Drawing lots, tossing a coin, shuffling cards, and throwing dice were adequate if performed by an independent person not otherwise involved in the trial. </p> </li> <li> <p>Uncertain risk of bias: The method of sequence generation was not specified.</p> </li> <li> <p>High risk of bias: The sequence generation method was not random.</p> </li> </ul> </p> <p><b>Allocation concealment</b> </p> <p> <ul id="CD003047-list-0004"> <li> <p>Low risk of bias: The participant allocations could not have been foreseen in advance of, or during, enrolment. Allocation was controlled by a central and independent randomisation unit. The allocation sequence was unknown to the investigators (e.g., if the allocation sequence was hidden in sequentially numbered, opaque, and sealed envelopes). </p> </li> <li> <p>Uncertain risk of bias: The method used to conceal the allocation was not described so that intervention allocations may have been foreseen in advance of, or during, enrolment. </p> </li> <li> <p>High risk of bias: The allocation sequence was likely to be known to the investigators who assigned the participants. </p> </li> </ul> </p> <p><b>Blinding of participants, personnel, and outcome assessors</b> </p> <p> <ul id="CD003047-list-0005"> <li> <p>Low risk of bias: Blinding was performed adequately, or the assessment of outcomes was not likely to be influenced by lack of blinding. </p> </li> <li> <p>Uncertain risk of bias: Information was insufficient to permit assessment of whether blinding was likely to induce bias on the results. </p> </li> <li> <p>High risk of bias: No blinding or incomplete blinding was performed, and assessment of outcomes was likely to be influenced by lack of blinding. </p> </li> </ul> </p> <p><b>Incomplete outcome data</b> </p> <p> <ul id="CD003047-list-0006"> <li> <p>Low risk of bias: Missing data were unlikely to make treatment effects depart from plausible values. Sufficient methods, such as multiple imputation, had been employed to handle missing data. </p> </li> <li> <p>Uncertain risk of bias: Information was insufficient to permit assessment of whether missing data in combination with the method used to handle missing data were likely to induce bias on the results. </p> </li> <li> <p>High risk of bias: The results were likely to be biased as the result of missing data.</p> </li> </ul> </p> <p><b>Selective outcome reporting</b> </p> <p> <ul id="CD003047-list-0007"> <li> <p>Low risk of bias: All outcomes were predefined and reported, or all clinically relevant and reasonably expected outcomes were reported. The trial was registered on the <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a> web site or on a similar register, or the protocol was published. </p> </li> <li> <p>Uncertain risk of bias: It was unclear whether all predefined and clinically relevant and reasonably expected outcomes were reported. </p> </li> <li> <p>High risk of bias: One or more clinically relevant and reasonably expected outcomes were not reported, and data on these outcomes were likely to have been recorded. </p> </li> </ul> </p> <p><b>Other bias</b> </p> <p> <ul id="CD003047-list-0008"> <li> <p>Low risk of bias: The trial appears to be free of other components that could put it at risk of bias.  </p> </li> <li> <p>Uncertain risk of bias: The trial may or may not be free of other components that could put it at risk of bias. </p> </li> <li> <p>High risk of bias: Other factors in the trial could put it at risk of bias (e.g., for‐profit involvement, authors conducting trials on the same topic). </p> </li> </ul> </p> <p>Trials with unclear or high risk of bias methodology in one or more of the above domains were considered trials with high risk of bias. The remaining were considered trials with low risk of bias. </p> </section> <section id="CD003047-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>All outcome measures were dichotomised and were expressed using odds ratios (ORs) with 95% confidence intervals (CIs). </p> </section> <section id="CD003047-sec-0044"> <h4 class="title">Unit of analysis issues</h4> <p>The primary analyses included data from trials using a parallel‐group design and from the first treatment period of cross‐over trials. Additional analyses were performed that included paired data from the cross‐over trials (<a href="./references#CD003047-bbs2-0020" title="BeckerMP , BalagtasCC . Marginal modelling of binary cross‐over data. Biometrics1993;49:997‐1009. [MEDLINE: PMID: 8117910] ">Becker 1993</a>; <a href="./references#CD003047-bbs2-0027" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31:140‐9. [MEDLINE: PMID: 11914310] ">Elbourne 2002</a>). </p> </section> <section id="CD003047-sec-0045"> <h4 class="title">Dealing with missing data</h4> <p>Data on all participants randomly assigned were sought to allow intention‐to‐treat analyses that included participants irrespective of compliance or follow‐up. For participants with missing data, carry‐forward of the last observed response was used. We originally planned to analyse the influence of missing data using imputation (<a href="./references#CD003047-bbs2-0033" title="HigginsJPT , WhiteIR , WoodAM . Imputation methods for missing outcome data in meta‐analysis of clinical trials. Clinical Trials2008;5:225‐39. ">Higgins 2008</a>). We planned to impute missing values as failures, successes, same as control group, same as experimental group, and same as own group (<a href="./references#CD003047-bbs2-0033" title="HigginsJPT , WhiteIR , WoodAM . Imputation methods for missing outcome data in meta‐analysis of clinical trials. Clinical Trials2008;5:225‐39. ">Higgins 2008</a>). We did not perform these analyses because no losses to follow‐up were described. </p> </section> <section id="CD003047-sec-0046"> <h4 class="title">Assessment of heterogeneity</h4> <p>Intertrial heterogeneity was assessed on the basis of I<sup>2</sup> values. </p> </section> <section id="CD003047-sec-0047"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to evaluate the risk of reporting bias by comparing trial protocols and published reports. Furthermore, reporting biases were assessed on the basis of the extent to which clinically relevant outcome measures (hepatic encephalopathy, mortality, and adverse events) were reported. </p> </section> <section id="CD003047-sec-0048"> <h4 class="title">Data synthesis</h4> <p>Analyses were performed in Review Manager 5 (<a href="./references#CD003047-bbs2-0047" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and in <a href="./references#CD003047-bbs2-0055" title="STATACorp LP, Texas USA. STATA 12. STATACorp LP, Texas USA, 2012. ">STATA 12</a> (<a href="./references#CD003047-bbs2-0055" title="STATACorp LP, Texas USA. STATA 12. STATACorp LP, Texas USA, 2012. ">STATA 12</a>). Primary meta‐analyses were performed by using random‐effects models because of anticipated variability between trials regarding participants and interventions. </p> </section> <section id="CD003047-sec-0049"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Originally, we planned to perform several subgroup analyses to assess sources of intertrial heterogeneity (bias control, participant characteristics, and intervention regimens). However, because of the limited number of trials in the meta‐analyses of the primary outcomes, we were able to perform these subgroup analyses only for the outcome measure of mortality. Likewise, regression analyses (Egger's test) that were planned to estimate the risk of publication bias and other biases (small‐study effects) were performed only for the outcome measure of mortality. </p> <section id="CD003047-sec-0050"> <h5 class="title">Trial sequential analysis</h5> <p>We performed trial sequential analysis (<a href="./references#CD003047-bbs2-0026" title="Copenhagen Trial Unit. TSA ‐ Trial Sequential Analysis. ctu.dk/tsa/ 2011 (accessed 4 September 2012). ">CTU 2011</a>; <a href="./references#CD003047-bbs2-0059" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual for Trial Sequential Analysis (TSA). http://ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 23 April 2013). ">Thorlund 2011</a>) to control risks of random errors due to sparse data and repetitive testing of cumulative data (<a href="./references#CD003047-bbs2-0022" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61:763‐9. ">Brok 2008</a>; <a href="./references#CD003047-bbs2-0060" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD003047-bbs2-0023" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. ">Brok 2009</a>; <a href="./references#CD003047-bbs2-0057" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses. International Journal of Epidemiology2009;38(1):276‐86. ">Thorlund 2009</a>; <a href="./references#CD003047-bbs2-0061" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. [DOI: 10] ">Wetterslev 2009</a>; <a href="./references#CD003047-bbs2-0058" title="ThorlundK , AnemaA , MillsE . Interpreting meta‐analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV‐infected individuals. Clinical Epidemiology2010;2:57‐66. ">Thorlund 2010</a>). To minimise the risk of random error, we calculated the required information size, defined as the required sample size necessary to detect or reject intervention effects after adjusting for diversity (<a href="./references#CD003047-bbs2-0022" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61:763‐9. ">Brok 2008</a>; <a href="./references#CD003047-bbs2-0060" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD003047-bbs2-0023" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. ">Brok 2009</a>; <a href="./references#CD003047-bbs2-0057" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses. International Journal of Epidemiology2009;38(1):276‐86. ">Thorlund 2009;</a><a href="./references#CD003047-bbs2-0061" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. [DOI: 10] ">Wetterslev 2009</a>; <a href="./references#CD003047-bbs2-0058" title="ThorlundK , AnemaA , MillsE . Interpreting meta‐analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV‐infected individuals. Clinical Epidemiology2010;2:57‐66. ">Thorlund 2010</a>). The information size was calculated on the basis of a risk ratio (RR) reduction of 20% or the results of included trials with a low risk of bias (<a href="./references#CD003047-bbs2-0022" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61:763‐9. ">Brok 2008</a>; <a href="./references#CD003047-bbs2-0060" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD003047-bbs2-0023" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. ">Brok 2009</a>; <a href="./references#CD003047-bbs2-0057" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses. International Journal of Epidemiology2009;38(1):276‐86. ">Thorlund 2009;</a><a href="./references#CD003047-bbs2-0061" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. [DOI: 10] ">Wetterslev 2009</a>; <a href="./references#CD003047-bbs2-0058" title="ThorlundK , AnemaA , MillsE . Interpreting meta‐analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV‐infected individuals. Clinical Epidemiology2010;2:57‐66. ">Thorlund 2010</a>). We presented the results of the analysis in a graph. with individual trials added on the basis of their year of publication. If more than one trial was published in a year, trials were added alphabetically according to the first author's family name. The results of the trials were presented as a cumulative Z‐curve. The trial sequential monitoring boundaries were constructed and the diversity‐adjusted required information size calculated with a type 1 error of 5% and a type 2 error of 20%. The results were displayed as a graph with the cumulative meta‐analysis results entered. The trial sequential analysis shows firm evidence of intervention effects (or no intervention effects) if the cumulative Z‐curve crosses the monitoring boundaries; it also shows that additional trials may be needed if the boundaries are not crossed. </p> </section> </section> <section id="CD003047-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>The robustness of the results was assessed by repeating the meta‐analyses using a fixed‐effect model. No additional sensitivity analyses were performed because of the limited number of trials identified. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003047-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003047-sec-0052"></div> <section id="CD003047-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD003047-sec-0054"> <h4 class="title">Results of the search</h4> <p>In total, 294 references were identified through the literature searches (<a href="./appendices#CD003047-sec-0080">Appendix 1</a>). After duplicates and clearly irrelevant references (references to papers that did not describe trials of dopaminergic agents for participants with hepatic encephalopathy) were excluded, 17 references were retrieved for further assessment (<a href="#CD003047-fig-0001">Figure 1</a>). Of these, eight references referred to five randomised trials that were eligible for inclusion (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0005" title="VijJC , TandonBN . Controlled trial of levodopa in fulminant hepatitis. Indian Journal of Medical Research1979;69:624‐8. [MEDLINE: PMID: 378825] ">Vij 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>; <a href="./references#CD003047-bbs2-0001" title="KoshyA , PratapB , DattaDV . Prospective randomised controlled trial of L‐dopa and hydrocortisone in fulminant hepatitis. Journal of the Association of Physicians of India1982;30(9):613‐4. [MEDLINE: 7184928] ">Koshy 1982</a>). Through correspondence with the authors of two trials (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>), additional information was obtained on trial results and methods. For the remaining trials, data were gathered from published reports. </p> <div class="figure" id="CD003047-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt=". Study flow diagram." data-id="CD003047-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><a href="#CD003047-fig-0001">Figure 1</a>. Study flow diagram. </p> </div> </div> </div> </section> <section id="CD003047-sec-0055"> <h4 class="title">Included studies</h4> <p>All of the included trials were described in at least one full‐paper article published from 1979 to 1982. Three trials used a parallel‐group design (<a href="./references#CD003047-bbs2-0005" title="VijJC , TandonBN . Controlled trial of levodopa in fulminant hepatitis. Indian Journal of Medical Research1979;69:624‐8. [MEDLINE: PMID: 378825] ">Vij 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0001" title="KoshyA , PratapB , DattaDV . Prospective randomised controlled trial of L‐dopa and hydrocortisone in fulminant hepatitis. Journal of the Association of Physicians of India1982;30(9):613‐4. [MEDLINE: 7184928] ">Koshy 1982</a>), and two trials used a cross‐over design (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). </p> <p>In total, 144 participants with overt hepatic encephalopathy were included. Three trials (66 participants in the treatment group versus 65 participants in the control group) assessed acute episodes of hepatic encephalopathy (<a href="./references#CD003047-bbs2-0005" title="VijJC , TandonBN . Controlled trial of levodopa in fulminant hepatitis. Indian Journal of Medical Research1979;69:624‐8. [MEDLINE: PMID: 378825] ">Vij 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980;</a><a href="./references#CD003047-bbs2-0001" title="KoshyA , PratapB , DattaDV . Prospective randomised controlled trial of L‐dopa and hydrocortisone in fulminant hepatitis. Journal of the Association of Physicians of India1982;30(9):613‐4. [MEDLINE: 7184928] ">Koshy 1982</a>). Two trials (seven participants in the treatment group versus six participants in the control group) assessed chronic hepatic encephalopathy (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). Two trials included participants with acute fulminant liver failure due to viral hepatitis (<a href="./references#CD003047-bbs2-0005" title="VijJC , TandonBN . Controlled trial of levodopa in fulminant hepatitis. Indian Journal of Medical Research1979;69:624‐8. [MEDLINE: PMID: 378825] ">Vij 1979</a>; <a href="./references#CD003047-bbs2-0001" title="KoshyA , PratapB , DattaDV . Prospective randomised controlled trial of L‐dopa and hydrocortisone in fulminant hepatitis. Journal of the Association of Physicians of India1982;30(9):613‐4. [MEDLINE: 7184928] ">Koshy 1982</a>). Three trials included participants with cirrhosis (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). The proportion of participants with alcoholic liver disease ranged from 0 to 80%. The proportion of participants with viral hepatitis ranged from 0 to 100%, and mean age ranged from 32 years to 57 years. </p> <p>Three trials assessed levodopa (<a href="./references#CD003047-bbs2-0005" title="VijJC , TandonBN . Controlled trial of levodopa in fulminant hepatitis. Indian Journal of Medical Research1979;69:624‐8. [MEDLINE: PMID: 378825] ">Vij 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980;</a><a href="./references#CD003047-bbs2-0001" title="KoshyA , PratapB , DattaDV . Prospective randomised controlled trial of L‐dopa and hydrocortisone in fulminant hepatitis. Journal of the Association of Physicians of India1982;30(9):613‐4. [MEDLINE: 7184928] ">Koshy 1982</a>), and two trials assessed bromocriptine (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). The mean daily dose was 4 grams for levodopa and 15 grams for bromocriptine. The median duration of treatment was 14 days (range seven to 56 days). None of the trials followed participants after the end of treatment. None of the included trials assessed health economics. </p> </section> <section id="CD003047-sec-0056"> <h4 class="title">Excluded studies</h4> <p>Nine references to eight trials were excluded because they turned out not to be randomised or referred to cross‐over trials that compared dopamine agents versus interventions for hepatic encephalopathy considered potentially active (<a href="./references#CD003047-sec-0089" title="">Characteristics of included studies</a>). </p> </section> </section> <section id="CD003047-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>All trials had a high risk of bias in the assessment of one or more than one of the bias risk domains. </p> <section id="CD003047-sec-0058"> <h4 class="title">Allocation</h4> <p>Randomisation methods (allocation sequence generation and allocation concealment) were classed as adequate in two trials (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>) and unclear in the remaining trials (<a href="#CD003047-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD003047-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt=". Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies." data-id="CD003047-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><a href="#CD003047-fig-0002">Figure 2</a>. Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="CD003047-sec-0059"> <h4 class="title">Blinding</h4> <p>Three trials were blinded using a placebo (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). No blinding was described in the remaining trials. </p> </section> <section id="CD003047-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>Two trials accounted for all participants with missing outcome data (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). In the remaining three trials, no dropouts or withdrawals were described, giving the impression that no losses to follow‐up occurred, although this was not specifically stated. </p> </section> <section id="CD003047-sec-0061"> <h4 class="title">Selective reporting</h4> <p>We were able to extract data on hepatic encephalopathy from only three trials (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). </p> </section> <section id="CD003047-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>No sample size calculations were reported. None of the included trials received industry funding. </p> </section> </section> <section id="CD003047-sec-0063"> <h3 class="title" id="CD003047-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD003047-tbl-0001"><b>Summary of findings for the main comparison</b> Dopamine agonists for hepatic encephalopathy</a> </p> <section id="CD003047-sec-0064"> <h4 class="title">Mortality</h4> <p>Random‐effects meta‐analyses found no difference in mortality between participants randomly assigned to dopamine agents versus controls (OR 1.11, 95% CI 0.34 to 3.54; <a href="./references#CD003047-fig-0004" title="">Analysis 1.1</a>). Little intertrial heterogeneity was noted (I<sup>2</sup> = 28%). The result was confirmed in a fixed‐effect meta‐analysis (OR 1.24, 95% CI 0.59 to 2.59). No evidence of small‐study effects was identified in regression analysis (Egger's test P value 0.35). In subgroup analyses, no clear differences were seen between trials on participants with acute episodes compared with chronic hepatic encephalopathy (<a href="./references#CD003047-fig-0005" title="">Analysis 1.2</a>) or participants with fulminant liver failure or cirrhosis (<a href="./references#CD003047-fig-0006" title="">Analysis 1.3</a>), trials on levodopa or bromocriptine (<a href="./references#CD003047-fig-0007" title="">Analysis 1.4</a>), trials with a low or unclear risk of bias (<a href="./references#CD003047-fig-0008" title="">Analysis 1.5</a>), or trials using a parallel or cross‐over design (<a href="./references#CD003047-fig-0009" title="">Analysis 1.6</a>). </p> <p>The trial sequential analysis graph showed that the cumulative Z‐curve does not cross the monitoring boundary (<a href="#CD003047-fig-0003">Figure 3</a>). The analysis showed a diversity‐adjusted required information size of 673 participants (the number of participants needed to reach firm evidence of an intervention effect of 20% risk ratio reduction). The number of participants included corresponds to only 21% of the diversity‐adjusted required information size. Accordingly, we lack evidence to recommend or refute dopamine agents for hepatic encephalopathy. </p> <div class="figure" id="CD003047-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Trial sequential analysis of dopamine agents versus placebo or no intervention in participants with hepatic encephalopathy.     The outcome measure is mortality. The analysis was performed with an event rate of 54% (Pc) in the control group, a risk ratio (RR) reduction of 20%, alpha 5%, beta 20%, and diversity 0%. The cumulative Z‐curve does not cross the naive 5% statistical boundaries (dotted horizontal lines) or the trial sequential boundaries for benefits or harms (inward sloping etched lines). The results show that the diversity‐adjusted required information size was 673 participants, corresponding to 21% of the total sample size in the included trials. The programme did not even draw futility boundaries. Accordingly, the meta‐analysis does not recommend or refute an intervention effect; data are simply too few." data-id="CD003047-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of dopamine agents versus placebo or no intervention in participants with hepatic encephalopathy.</b> <br/> <br/> The outcome measure is mortality. The analysis was performed with an event rate of 54% (Pc) in the control group, a risk ratio (RR) reduction of 20%, alpha 5%, beta 20%, and diversity 0%. The cumulative Z‐curve does not cross the naive 5% statistical boundaries (dotted horizontal lines) or the trial sequential boundaries for benefits or harms (inward sloping etched lines). The results show that the diversity‐adjusted required information size was 673 participants, corresponding to 21% of the total sample size in the included trials. The programme did not even draw futility boundaries. Accordingly, the meta‐analysis does not recommend or refute an intervention effect; data are simply too few. </p> </div> </div> </div> </section> <section id="CD003047-sec-0065"> <h4 class="title">Hepatic encephalopathy</h4> <p>The primary random‐effects meta‐analyses showed no significant effects of dopamine agents on hepatic encephalopathy compared with placebo or no intervention when data from parallel‐group trials were analysed (OR 0.33, 95% CI 0.01 to 11.25; <a href="./references#CD003047-fig-0010" title="">Analysis 1.7</a>) or when paired data from the cross‐over trial reporting this outcome measure were included (OR 0.68, 95% CI 0.17 to 2.67; <a href="./references#CD003047-fig-0011" title="">Analysis 1.8</a>). The results were confirmed by fixed‐effect meta‐analyses including data from parallel‐group trials (OR 1.08, 95% CI 0.45 to 2.62), but also when paired data from the two cross‐over trials reporting this outcome measure were included (OR 1.04, 95% CI 0.75 to 1.43). </p> </section> <section id="CD003047-sec-0066"> <h4 class="title">Adverse events</h4> <p>We were able to retrieve data on adverse events only from the two cross‐over trials (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). In total, seven of 13 participants experienced non‐serious adverse events during treatment with dopamine agents. No adverse events were reported during control periods. No clear difference was observed between intervention and control groups (<a href="./references#CD003047-fig-0012" title="">Analysis 1.9</a>). No serious adverse events were registered. Adverse events included hypomania (n = 1), hallucinations and headache (n = 1), constipation (n = 3), and nausea and vomiting (n = 2). </p> </section> <section id="CD003047-sec-0067"> <h4 class="title">Quality of life</h4> <p>None of the included trials reported data on quality of life.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003047-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003047-sec-0068"></div> <section id="CD003047-sec-0069"> <h3 class="title" id="CD003047-sec-0069">Summary of main results</h3> <p>Patients with cirrhosis may present with extrapyramidal symptoms similar to those seen in Parkinson's disease (<a href="./references#CD003047-bbs2-0037" title="JoverR , CompanyL , GutierrezA , ZapaterP , Perez‐SerraJ , GironaE , et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. American Journal of Gastroenterology2003;98:1599‐604. [MEDLINE: PMID: 12873585] ">Jover 2003</a>). Further similarities between participants with hepatic encephalopathy and participants with Parkinson's disease include alterations in the basal ganglia (<a href="./references#CD003047-bbs2-0052" title="SpahrL , VingerhoetsF , LazeyrasF , DelavelleJ , DuPasquierR , GiostraE , et al. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology2000;119:774‐81. [MEDLINE: 10982772] ">Spahr 2000</a>). In theory, dopamine agents that are effective in Parkinson's disease could alleviate manifestations of hepatic encephalopathy. However, the present systematic review found no evidence to recommend or refute the use of dopamine agents for patients with hepatic encephalopathy. The available evidence includes only a limited number of small trials published before 1983. No clear effects were identified for any of the outcome measures assessed. Additional analyses found no specific subgroups that indicated potential effects when the results of included trials were separated on the basis of the type of hepatic encephalopathy at inclusion, the type of underlying liver disease, or the intervention assessed. The dose and duration of the interventions assessed were similar across trials. Data from participants with Parkinson's disease (<a href="./references#CD003047-bbs2-0042" title="MiyasakiJM , MartinW , SuchowerskyO , WeinerWJ , LangAE . Practice parameter: initiation of treatment for Parkinson's disease: an evidence‐based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology. American Academy of Neurology2002;58:11‐7. [MEDLINE: PMID: 12391377] ">Miyasaki 2002</a>) show that the dose of both levodopa and bromocriptine and the duration of the intervention regimens assessed in included trials should be sufficiently high to detect a clinical response. The combined evidence is not promising. However, the statistical power is low, and evidence is insufficient to support or refute beneficial or harmful effects of the interventions assessed. </p> </section> <section id="CD003047-sec-0070"> <h3 class="title" id="CD003047-sec-0070">Overall completeness and applicability of evidence</h3> <p>To ensure completeness of the evidence, we performed extensive literature searches. Our regression analyses showed no clear evidence of publication bias or other small‐study effects. Still, the regression analysis was not sensitive because of the limited number of trials. </p> <p>The main problem with the included trials is the fact that a number of potentially effective interventions for patients with decompensated liver disease have been identified after the trials were completed. These interventions include treatments for hepatic encephalopathy (<a href="./references#CD003047-bbs2-0019" title="BassNM , MullenKD , SanyalA , PoordadF , NeffG , LeevyCB , et al. Rifaximin treatment in hepatic encephalopathy. New England Journal of Medicine2010;362(12):1071‐81. [PUBMED: 20335583] ">Bass 2010</a>), bleeding oesophageal varices (<a href="./references#CD003047-bbs2-0015" title="AbraldesJG , BoschJ . The treatment of acute variceal bleeding. Journal of Clinical Gastroenterology2007;41(Suppl 3):S312‐S317. [PUBMED: 17975482] ">Abraldes 2007</a>), and spontaneous bacterial peritonitis (<a href="./references#CD003047-bbs2-0062" title="WiestR , KragA , GerbesA . Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut2012;61(2):297‐310. [PUBMED: 22147550] ">Wiest 2012</a>). Likewise, the diagnostic assessment and nomenclature for hepatic encephalopathy have been updated (<a href="./references#CD003047-bbs2-0017" title="BajajJS , CordobaJ , MullenKD , AmodioP , ShawcrossDL , ButterworthRF , et al. Review article: the design of clinical trials in hepatic encephalopathy ‐ an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Alimentary Pharmacology &amp; Therapeutics2011;33(7):739‐47. [PUBMED: 21306407] ">Bajaj 2011</a>). Accordingly, extrapolation of results from the present review to current clinical practice is of limited value. </p> </section> <section id="CD003047-sec-0071"> <h3 class="title" id="CD003047-sec-0071">Quality of the evidence</h3> <p>Adequate internal validity depends on the control of bias and random errors. Because three trials had unclear randomisation (<a href="./references#CD003047-bbs2-0002" title="MichelH , CauvetG , GranierPM , BaliJP , CuilleretA , CuilleretG . Treatment of cirrhotic hepatic encephalopathy by L‐dopa. A double‐blind study of 58 patients [abstract]. Digestion1977; Vol. 15:232‐3. MichelH , SolereM , GranierP , CauvetG , BaliJP , PonsF , et al. Treatment of cirrhotic hepatic encephalopathy with L‐dopa. A controlled trial. Gastroenterology1980;79(2):207‐11. [MEDLINE: 6995221] ">Michel 1980</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>; <a href="./references#CD003047-bbs2-0001" title="KoshyA , PratapB , DattaDV . Prospective randomised controlled trial of L‐dopa and hydrocortisone in fulminant hepatitis. Journal of the Association of Physicians of India1982;30(9):613‐4. [MEDLINE: 7184928] ">Koshy 1982</a>) and consequently an unclear control of selection bias, the internal validity of their results and of the results of our meta‐analyses can be questioned. The use of a cross‐over design as applied in two of the included trials (<a href="./references#CD003047-bbs2-0004" title="UribeM , FarcaA , MarquezMA , Garcia RamosG , GuevaraL . Treatment of chronic portal systemic encephalopathy with bromocriptine: a double‐blind controlled trial. Gastroenterology1979;76(6):1347‐51. [MEDLINE: 374177] ">Uribe 1979</a>; <a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>) is also debatable. Even chronic hepatic encephalopathy may have a fluctuating course (<a href="./references#CD003047-bbs2-0018" title="BasileAS , JonesEA , SkolnickP . The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacological Reviews1991;43(1):27‐71. [MEDLINE: 91239624] ">Basile 1991</a>); therefore, manifestations of hepatic encephalopathy may change during the course of the trial, irrespective of the interventions assessed. The underlying condition and the ability to respond to treatment may not remain stable from the first to the second treatment period. We therefore used only data from the first study period of the cross‐over trials in our primary analyses. Unfortunately, these data were available for only one trial (<a href="./references#CD003047-bbs2-0003" title="MorganMY . Bromocriptine in the treatment of chronic hepatic encephalopathy. In: CapocacciaL , FischerJE , Rossi‐FanelliF editor(s). Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:255‐65. MorganMY , JakobovitsAW , JamesIM , LennoxR , SherlockS . Bromocriptine in the treatment of chronic portal systemic encephalopathy [abstract]. Gut1978; Vol. 19, issue Suppl 2:A453. MorganMY , JakobovitsAW , JamesIM , SherlockS . Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology1980;78(4):663‐70. [MEDLINE: 7353752] ">Morgan 1980</a>). The sensitivity analysis on paired data did not change our overall result. </p> </section> <section id="CD003047-sec-0072"> <h3 class="title" id="CD003047-sec-0072">Potential biases in the review process</h3> <p>Identification and selection of trials are essential to the assessment of bias in the review process. To limit bias in the selection process, we included trials irrespective of language or publication status. We also chose to include trials regardless of the dose or duration of the interventions assessed. This led to a relatively heterogeneous group of trials. We did, however, choose to exclude trials with an active comparison group. This choice was made on the basis of lack of evidence supporting several of the interventions assessed for patients with hepatic encephalopathy. The strategy resulted in the exclusion of two small, low‐quality, cross‐over trials on chronic hepatic encephalopathy (<a href="./references#CD003047-bbs2-0010" title="MessnerM , LeGallJ‐Y , ToulouseP , JavaudinL , DelamaireD , BrissotP , et al. Plasma ratio of branched chain/aromatic amino acids during treatment of chronic hepatic encephalopathy using lactulose/bromocriptine in a double blind procedure [EASL abstract]. Liver1982;2(3 Pt 2):312. [EMBASE: 1983020208] ">Messner 1982</a>; <a href="./references#CD003047-bbs2-0014" title="UribeM , Garcia RamosG , RamosM , ValverdeC , MarquezMA , FarcaA , et al. Standard and higher doses of bromocriptine for severe chronic portal‐systemic encephalopathy. American Journal of Gastroenterology1983;78(8):517‐22. [MEDLINE: 6881119] UribeM , MarquezMA , GuevaraL , Garcia RamosG . Bromocriptine for severe chronic portal systemic encephalopathy [abstract]. Gastroenterology1982;82:1201. ">Uribe 1983</a>). The control groups in these trials received lactulose or neomycin, which could affect the course of hepatic encephalopathy. The total number of participants randomly assigned in these two trials was only 15, and this limits the value of these results. </p> </section> <section id="CD003047-sec-0073"> <h3 class="title" id="CD003047-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>At present, dopamine agents are not recommended for patients with hepatic encephalopathy. Previous guidelines state that bromocriptine may be considered for patients with chronic hepatic encephalopathy that is unresponsive to other interventions (<a href="./references#CD003047-bbs2-0021" title="BleiA . Hepatic encephalopathy. In: BircherJ , BenhamouJ‐P , McIntyreN , RizzettoM , RodésJ editor(s). Clinical Hepatology. 2nd Edition. Vol. 1, Oxford: Oxford University Press, 1999:765‐83. ">Blei 1999</a>). In agreement with more recent recommendations (<a href="./references#CD003047-bbs2-0045" title="PhongsamranPV , KimJW , Cupo AbbottJ , RosenblattA . Pharmacotherapy for hepatic encephalopathy. Drugs2010;70(9):1131‐48. [PUBMED: 20518580] ">Phongsamran 2010</a>), the present review contradicts these recommendations, suggesting that no evidence is available to support the use of dopamine agents for chronic hepatic encephalopathy. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003047-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt=". Study flow diagram." data-id="CD003047-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p><a href="#CD003047-fig-0001">Figure 1</a>. Study flow diagram. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt=". Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies." data-id="CD003047-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p><a href="#CD003047-fig-0002">Figure 2</a>. Risk of bias graph: review authors' judgements about all risk of bias items presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of dopamine agents versus placebo or no intervention in participants with hepatic encephalopathy.     The outcome measure is mortality. The analysis was performed with an event rate of 54% (Pc) in the control group, a risk ratio (RR) reduction of 20%, alpha 5%, beta 20%, and diversity 0%. The cumulative Z‐curve does not cross the naive 5% statistical boundaries (dotted horizontal lines) or the trial sequential boundaries for benefits or harms (inward sloping etched lines). The results show that the diversity‐adjusted required information size was 673 participants, corresponding to 21% of the total sample size in the included trials. The programme did not even draw futility boundaries. Accordingly, the meta‐analysis does not recommend or refute an intervention effect; data are simply too few." data-id="CD003047-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p><b>Trial sequential analysis of dopamine agents versus placebo or no intervention in participants with hepatic encephalopathy.</b> <br/> <br/> The outcome measure is mortality. The analysis was performed with an event rate of 54% (Pc) in the control group, a risk ratio (RR) reduction of 20%, alpha 5%, beta 20%, and diversity 0%. The cumulative Z‐curve does not cross the naive 5% statistical boundaries (dotted horizontal lines) or the trial sequential boundaries for benefits or harms (inward sloping etched lines). The results show that the diversity‐adjusted required information size was 673 participants, corresponding to 21% of the total sample size in the included trials. The programme did not even draw futility boundaries. Accordingly, the meta‐analysis does not recommend or refute an intervention effect; data are simply too few. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 1 Mortality." data-id="CD003047-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 2 Mortality stratified by type of hepatic encephalopathy." data-id="CD003047-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 2 Mortality stratified by type of hepatic encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 3 Mortality stratified by liver disease." data-id="CD003047-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 3 Mortality stratified by liver disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 4 Mortality stratified by intervention." data-id="CD003047-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 4 Mortality stratified by intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 5 Mortality stratified by bias risk." data-id="CD003047-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 5 Mortality stratified by bias risk. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 6 Mortality stratified by trial design." data-id="CD003047-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 6 Mortality stratified by trial design. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 7 Hepatic encephalopathy." data-id="CD003047-fig-0010" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 7 Hepatic encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 8 Hepatic encephalopathy paired data." data-id="CD003047-fig-0011" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 8 Hepatic encephalopathy paired data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003047-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/urn:x-wiley:14651858:media:CD003047:CD003047-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_t/tCD003047-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 9 Adverse events paired data." data-id="CD003047-fig-0012" src="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Dopamine agonists versus placebo or no intervention, Outcome 9 Adverse events paired data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/media/CDSR/CD003047/image_n/nCD003047-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003047-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dopamine agonists for hepatic encephalopathy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Dopamine agonists versus placebo or no intervention for hepatic encephalopathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with hepatic encephalopathy.<br/> <b>Settings:</b> hospitalised patients.<br/> <b>Intervention:</b> dopamine agonists versus placebo or no intervention. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control (placebo or no intervention)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Dopamine agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> <br/> Follow‐up: mean one month </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.11</b> <br/> (0.35 to 3.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>144<br/> (five studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>535 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> <br/> (287 to 803) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>395 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>420 per 1000</b> <br/> (186 to 698) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Hepatic encephalopathy</b> <br/> Follow‐up: mean one month </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.99</b> <br/> (0.09 to 100.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>80<br/> (two studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>350 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>617 per 1000</b> <br/> (46 to 982) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>184 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>403 per 1000</b> <br/> (20 to 958) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The randomisation methods were classed as adequate in two trials, and three trials were double‐blind.<br/> <sup>2</sup>The sample size was small, and the statistical power of included trials was weak.<br/> <sup>3</sup>Because of the small number of trials, tests for publication bias were of limited value. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Dopamine agonists for hepatic encephalopathy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/full#CD003047-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003047-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dopamine agonists versus placebo or no intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.35, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality stratified by type of hepatic encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.35, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Acute episode of hepatic encephalopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.34, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Chronic hepatic encephalopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.01, 8.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality stratified by liver disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.35, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Fulminant liver failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.05, 22.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Cirrhosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.54, 3.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality stratified by intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.35, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Levodopa</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.34, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Bromocriptine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.01, 8.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality stratified by bias risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.59, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Low bias risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.01, 8.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Unclear bias risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.63, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mortality stratified by trial design <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.35, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Parallel group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.34, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Cross‐over</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.01, 8.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Hepatic encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.99 [0.09, 100.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Hepatic encephalopathy paired data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.17, 2.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Adverse events paired data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>OR (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.12 [‐0.99, 5.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dopamine agonists versus placebo or no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003047.pub3/references#CD003047-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003047.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003047-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003047-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003047-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD003047-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD003047-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003047\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003047\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003047\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003047\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003047\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XHP2gG4h&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003047.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003047.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003047.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003047.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003047.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719058148"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003047.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719058152"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003047.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddf77ab841be4',t:'MTc0MDcxOTA1OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 